Results 111 to 120 of about 5,633 (170)

Prunus amygdalus var. amara seed extract enhances the antileishmanial activity of miltefosine. [PDF]

BMC Complement Med Ther
Akand SK, Rahman A, Ali R, Husain M, Danish M, Khan MR, Ali N, Akram MF, Rub A.   +8 more
europepmc   +1 more source

Visceral Leishmaniasis in Southern Brazil: an overview of current epidemiology. [PDF]

Rev Soc Bras Med Trop
Dambrós BP, Rosar AS, Stoco PH, Quaresma PF, Grisard EC, Steindel M.   +5 more
europepmc   +1 more source

Off-label treatment with miltefosine for complex, pediatric Old World cutaneous leishmaniasis. [PDF]

JAAD Case Rep
Buchelt M, Valero T, Kinaciyan T, Walochnik J, Egg M, Szelenyi A, Langer S, Handisurya A.   +7 more
europepmc   +1 more source

Post-kala-azar dermal leishmaniasis: insights into underlying pathogenic mechanisms and genetic landscape. [PDF]

Front Microbiol
Mukherjee S, Karmakar S, Singh VK, Kumar R, Sundar S.   +4 more
europepmc   +1 more source

Combination Therapy for the Treatment of Cutaneous Leishmaniasis Compared with Standard Drugs, <i>In Vitro</i> or <i>In Vivo</i>: A Systematic Review. [PDF]

Adv Biomed Res
Mousavi P, Zolfaghari A, Aghaei M, Heidari A, Shahmoradi Z, Hejazi SH.   +5 more
europepmc   +1 more source

Discovery of Cyclopentane-Based Phospholipids as Miltefosine Analogs with Superior Potency and Enhanced Selectivity Against <i>Naegleria fowleri</i>. [PDF]

Pharmaceuticals (Basel)
Hassan AHE, Lê HG, Võ TC, Kim M, No JH, Aboutaleb MH, Sim J, Na BK, Lee YS.   +8 more
europepmc   +1 more source

Advancing Insights Into Visceral Leishmaniasis: Challenges, Innovations, and Future Directions in Global Disease Management. [PDF]

J Parasitol Res
Abbasi E.
europepmc   +1 more source

Nucleoside Analogue with Thymidine Nucleobase Inhibits <i>Leishmania infantum</i> and Depolarizes the Plasma Membrane Potential In Vitro. [PDF]

ACS Omega
Menezes C, Dias IO, Pileggi E, Tempone AG, Pertusati F, Borborema SET.   +5 more
europepmc   +1 more source